Search results
Psychoactive drugs are having a moment. The FDA will soon weigh in
The State· 11 hours agoPsychoactive drugs are having a moment. Investors are piling into the nascent field, and a host of medications based on MDMA, LSD, psychedelic mushrooms, ketamine, the South ...
Magic Mushrooms Get Canadian Export License in Psychedelic Race
Bloomberg via Yahoo Finance· 6 hours ago(Bloomberg) -- Canada has licensed a startup to export psychedelics to Australia for patient use,...
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
Associated Press· 3 days agoFederal health regulators are questioning the safety and evidence behind the first bid to use MDMA,...
MDMA Is Up For FDA Approval. Critics Are Questioning Whether It Works
Bloomberg· 4 days agoAlmost forty years after it was banned, it’s taking a big step toward becoming a licensed treatment...
F.D.A.’s Review of MDMA Cites Health Risks and Study Flaws
New York Times· 3 days agoThe Food and Drug Administration on Friday raised concerns about the health effects of MDMA as a...
FDA’s review of MDMA for PTSD highlights study bias and safety concerns
Ars Technica· 3 days agoThe safety and efficacy data on the use of MDMA (aka ecstasy) for post-traumatic stress disorder...
Landmark review spotlights challenge of judging psychedelic therapies
Axios· 9 hours agoDriving the news: A Food and Drug Administration panel of outside experts on Tuesday will evaluate Lykos Therapeutics' application to use the drug known as ecstasy to treat PTSD. MDMA ...
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
WPXI· 3 days agoWASHINGTON — (AP) — Federal health regulators are questioning the safety and evidence behind the...
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
Dayton Daily News· 3 days agoWASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first...
The FDA is weighing whether to approve MDMA for PTSD. Here's what that could look like for patients.
CBS News· 3 days agoAhead of a key meeting Tuesday to weigh the potential approval of midomafetamine, or MDMA, for...